Clinical Trials Directory

Trials / Completed

CompletedNCT01713413

Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases

Effects of an Oxymizer Versus Conventional Nasal Cannula on Endurance Time in Patients With Chronic Obstructive Pulmonary Disease IV (COPD) or Interstitial Lung Disease (ILD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Schön Klinik Berchtesgadener Land · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The Oxymizer pendant® is a special oxygen cannula that can be used to supply high flow long term oxygen therapy. It is compatible with a wide variety of oxygen sources. In a reservoir, the Oxymizer® stores pure oxygen so that the concentration of inhaled oxygen is increased. The aim of this study is to investigate the potential benefit of the Oxymizer® with regard to the blood oxygenation during exercise testing. Given that the "endurance time" is very sensitive for little changes in exercise capacity, this test will be used to show the difference between the Oxymizer® and a conventional nasal cannula regarding exercise duration at 70% of peak Watt and oxygenation. The tests will be accompanied by blood gas analysis, partial pressure of carbon dioxide and heart rate.

Conditions

Interventions

TypeNameDescription
DEVICEOxymizerUsing first the Oxymizer and 24 h later the conventional nasal cannula.
DEVICEconventional nasal cannulaUsing first the conventional nasal cannula and 24h later the Oxymizer

Timeline

Start date
2012-02-01
Primary completion
2014-02-01
Completion
2014-03-01
First posted
2012-10-24
Last updated
2014-04-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01713413. Inclusion in this directory is not an endorsement.